|
1
|
Haugen BR, Alexander EK, Bible KC, Doherty
GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM,
Schlumberger M, et al: 2015 American thyroid association management
guidelines for adult patients with thyroid nodules and
differentiated thyroid cancer: The American thyroid association
guidelines task force on thyroid nodules and differentiated.
Thyroid. 26:1–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
La Vecchia C, Malvezzi M, Bosetti C,
Garavello W, Bertuccio P, Levi F and Negri E: Thyroid cancer
mortality and incidence: A global overview. Int J Cancer.
136:2187–2195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zimmermann MB and Galetti V: Iodine intake
as a risk factor for thyroid cancer: A comprehensive review of
animal and human studies. Thyroid Res. 8:82015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeon MJ, Kim WG, Choi YM, Kwon H, Lee YM,
Sung TY, Yoon JH, Chung KW, Hong SJ, Kim TY, et al: Features
predictive of distant metastasis in papillary thyroid
microcarcinoma. Thyroid. 26:161–168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lara E, Calvanese V, Huidobro C, Fernández
AF, Moncada-Pazos A, Obaya AJ, Aguilera O, González-Sancho JM,
Sánchez L, Astudillo A, et al: Epigenetic repression of ROR2 has a
Wnt-mediated, pro-tumourigenic role in colon cancer. Mol Cancer.
9:1702010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rasmussen NR, Debebe Z, Wright TM, Brooks
SA, Sendor AB, Brannon AR, Hakimi AA, Hsieh JJ, Choueiri TK,
Tamboli P, et al: Expression of Ror2 mediates invasive phenotypes
in renal cell carcinoma. PLoS One. 9:e1161012014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
International Agency for Research on
Cancer: World Health Organization Classification of Tumours:
Pathology and Genetics of Tumours of Endocrine Organs. DeLellis RA,
Lloyd VR, Heitz PU and Eng C: IARC Press; Lyon, France: 8. 3rd. pp.
3202004
|
|
8
|
Sastre-Perona A and Santisteban P: Role of
the wnt pathway in thyroid cancer. Front Endocrinol (Lausanne).
3:312012.PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lim H, Devesa SS, Sosa JA, Check D and
Kitahara CM: Trends in thyroid cancer incidence and mortality in
the United States, 1974–2013. JAMA. 317:1338–1348. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
La Greca A, Xu B, Ghossein R, Tuttle RM
and Sabra MM: Patients with multifocal macroscopic papillary
thyroid carcinoma have a low risk of recurrence at early follow-up
after total thyroidectomy and radioactive iodine treatment. Eur
Thyroid J. 6:31–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carhill AA, Litofsky DR, Ross DS, Jonklaas
J, Cooper DS, Brierley JD, Ladenson PW, Ain KB, Fein HG, Haugen BR,
et al: Long-term outcomes following therapy in differentiated
thyroid carcinoma: NTCTCS registry analysis 1987–2012. J Clin
Endocrinol Metab. 100:3270–3279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cerutti JM, Latini FR, Nakabashi C,
Delcelo R, Andrade VP, Amadei MJ, Maciel RM, Hojaij FC, Hollis D,
Shoemaker J and Riggins GJ: Diagnosis of suspicious thyroid nodules
using four protein biomarkers. Clin Cancer Res. 12:3311–3318. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zou M, Baitei EY, Alzahrani AS, BinHumaid
FS, Alkhafaji D, Al-Rijjal RA, Meyer BF and Shi Y: Concomitant RAS,
RET/PTC, or BRAF mutations in advanced stage of papillary thyroid
carcinoma. Thyroid. 24:1256–1266. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Henry C, Llamosas E, Knipprath-Meszaros A,
Schoetzau A, Obermann E, Fuenfschilling M, Caduff R, Fink D, Hacker
N, Ward R, et al: Targeting the ROR1 and ROR2 receptors in
epithelial ovarian cancer inhibits cell migration and invasion.
Oncotarget. 6:40310–40326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim YH, Choi YW, Han JH, Lee J, Soh EY,
Park SH, Kim JH and Park TJ: TSH signaling overcomes
B-RafV600E-induced senescence in papillary thyroid carcinogenesis
through regulation of DUSP6. Neoplasia. 16:1107–1120. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheung R, Kelly J and Macleod RJ:
Regulation of villin by wnt5a/ror2 signaling in human intestinal
cells. Front Physiol. 2:582011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
O'Connell MP, Fiori JL, Xu M, Carter AD,
Frank BP, Camilli TC, French AD, Dissanayake SK, Indig FE, Bernier
M, et al: The orphan tyrosine kinase receptor, ROR2, mediates wnt5A
signaling in metastatic melanoma. Oncogene. 29:34–44. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edris B, Espinosa I, Mühlenberg T, Mikels
A, Lee CH, Steigen SE, Zhu S, Montgomery KD, Lazar AJ, Lev D, et
al: ROR2 is a novel prognostic biomarker and a potential
therapeutic target in leiomyosarcoma and gastrointestinal stromal
tumour. J Pathol. 227:223–233. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wright TM and Rathmell WK: Identification
of Ror2 as a hypoxia-inducible factor target in von
hippel-lindau-associated renal cell carcinoma. J Biol Chem.
285:12916–12924. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wright TM, Brannon AR, Gordan JD, Mikels
AJ, Mitchell C, Chen S, Espinosa I, van de Rijn M, Pruthi R, Wallen
E, et al: Ror2, a developmentally regulated kinase, promotes tumor
growth potential in renal cell carcinoma. Oncogene. 28:2513–2523.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Enomoto M, Hayakawa S, Itsukushima S, Ren
DY, Matsuo M, Tamada K, Oneyama C, Okada M, Takumi T, Nishita M and
Minami Y: Autonomous regulation of osteosarcoma cell invasiveness
by Wnt5a/Ror2 signaling. Oncogene. 28:3197–3208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McDonald SL and Silver A: The opposing
roles of Wnt-5a in cancer. Br J Cancer. 101:209–214. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nomachi A, Nishita M, Inaba D, Enomoto M,
Hamasaki M and Minami Y: Receptor tyrosine kinase Ror2 mediates
Wnt5a-induced polarized cell migration by activating c-Jun
N-terminal kinase via actin-binding protein filamin A. J Biol Chem.
283:27973–27981. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun B, Ye X, Lin L, Shen M and Jiang T:
Up-regulation of ROR2 is associated with unfavorable prognosis and
tumor progression in cervical cancer. Int J Clin Exp Pathol.
8:856–861. 2015.PubMed/NCBI
|
|
26
|
Lara E, Calvanese V, Huidobro C, Fernández
AF, Moncada-Pazos A, Obaya AJ, Aguilera O, González-Sancho JM,
Sánchez L, Astudillo A, et al: Epigenetic repression of ROR2 has a
Wnt-mediated, pro-tumourigenic role in colon cancer. Mol Cancer.
9:1702010. View Article : Google Scholar : PubMed/NCBI
|
